Regarding therapeutic targets related to NETs in lung cancer, it was previously revealed that the DAMP protein HMGB1 released by lung cancer cells contributes to the induction of NETs that was dependent on the activation of TLR4 (92). This evidence concerns the gene TLR4 and lung carcinoma.